Related Experiment Videos
Linking two immuno-suppressive molecules: indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression
Alvaro González-Hernandez1, Joël LeMaoult, Ana Lopez
1Clínica Universitaria de Navarra, 31080 Pamplona, Navarra, Spain.
Biology of Reproduction
|May 10, 2005
Summary
The study reveals a link between human leukocyte antigen (HLA)-G expression and indoleamine 2,3 dioxygenase (INDO) function. Inhibiting or boosting INDO activity altered HLA-G expression on antigen-presenting cells, impacting immune tolerance.
Area of Science:
- Immunology
- Cell Biology
- Reproductive Biology
Background:
- Nonclassical human leukocyte antigen (HLA) class I molecule HLA-G and indoleamine 2,3 dioxygenase (INDO) are key immunosuppressors in fetal-maternal tolerance.
- HLA-G inhibits T cell and natural killer cell function, while INDO depletes tryptophan, hindering T cell proliferation.
Purpose of the Study:
- To investigate the potential link between HLA-G expression and INDO function.
- To understand the regulatory mechanisms governing HLA-G expression in the context of INDO activity.
Main Methods:
- Utilized antigen-presenting cell (APC) lines and primary monocytes.
- Manipulated INDO function using 1-methyl-tryptophan (INDO inhibition) and high tryptophan concentrations (INDO boost).
- Assessed cell surface expression of HLA-G1 and intracellular HLA-G protein levels.
Main Results:
- Functional inhibition of INDO induced cell surface HLA-G1 expression in previously negative APCs.
- Boosting INDO function led to a complete loss of cell surface HLA-G1 expression in positive APCs.
- The observed regulation was post-translational, as intracellular HLA-G protein content remained unchanged.
Conclusions:
- HLA-G cell surface expression is regulated by INDO function, not solely by tryptophan levels.
- This interaction may play a significant role in maintaining fetal-maternal tolerance.
- Further research is warranted to elucidate the precise molecular mechanisms involved.